BSN: Imperial Innovations increases stake in OSspray

Improve Your Rank!

People, Speakers

Abstracts, Posters

What's My Rank?
      What's My Popularity Score?
      In My Orgs?
      In My Specialities?
      In My Geography?
      In My Age?

My Mentors, Collaborators,
Associates, Peers, Buddies

Keep Me Up To Date
Specialty, Keyword,
Geography

People Making News

Latest Research From
Meetings

Recent Postings

People of Consequence (40202)

1. Richard M. Satava
University of Washington
2. Adam P Dicker
Thomas Jefferson University
3. Lena Specht
Copenhagen University
4. Richard G. Pestell
Kimmel Cancer Center
5. Warren M. Jackman
University of Oklahoma

Orgs of Consequence (10419)

1. University of California
2. Harvard University
3. Mayo Clinic
4. National Institutes of Health, Chemical Genomics Centre
5. M. D. Anderson Cancer Center

Terms of Consequence

1. Cells
2. Cancer
3. Genetics
4. Molecular
5. Proteins

Imperial Innovations increases stake in OSspray

Friday, July 3

Imperial Innovations (AIM: IVO, "Imperial Innovations"), a leading technology commercialisation and investment company, has increased its stake in OSspray, an emerging speciality dental company, following a further drawdown of £980,000 under its existing funding arrangements.

http://www.smallcapnews.co.uk/article/Imperial_Innovations_increases_stake_in_dental_technology_specialist_OSspray_/7811.aspx

Comments

About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community

BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.